Mice study: Faecal virus transplant shows promise in combating obesity and diabetes
In recent years, faecal transplants from healthy donors to sick patients have become a popular way of treating a serious type of diarrhoea caused by the bacterium Clostridioides difficile in humans. Recent trials in mice suggest that a similar treatment, in which only the virus in stool is transplanted, may help people suffering from obesity and type 2 diabetes. The majority of virus particles transmitted are so-called bacteriophages — viruses that specifically attack other bacteria and not humans, reducing the potential risk of inadvertently transmitting disease.
Dennis Sandris Nielsen, Professor with Special Responsibilities (MSO) at the University of Copenhagen’s Department of Food Science and senior author of the study published in BMJ Gut, says: "When we transmit virus particles from the faeces of lean mice to obese ones, the obese mice put on significantly less weight compared to those that do not receive transplanted faeces."
According the the study, this method also seems to protect the mice against developing glucose intolerance, a hall mark of type 2 diabetes, a disease that inhibits the body from properly absorbing sugar. The experiments demonstrated that the obese mice that received an intestinal virus transplant from lean mice reacted to a shot of glucose no differently than the lean ones.
First author of the study PhD student Torben Sølbeck Rasmussen, explains: "In the obese mice on high fat diet, that didn’t receive the virus transplant, we observed decreased glucose tolerance, which is a precursor of diabetes. Thus, we have influenced the gut microbiome in such a way that the mice with unhealthy lifestyles do not develop some of the common diseases triggered by poor diet."
He emphasises that the method is not a stand-alone solution and that it must be complemented with a change in diet. Furthermore, the treatment will probably not be targeted at general obesity, but more towards the most serious cases.
It is understood that obesity and type 2 diabetes are linked to imbalances in the gastrointestinal microbiome.
"If one eats poorly for long enough, they risk creating an imbalance in their intestinal tract. Here, we have a means of recuperating balance by shooting missing virus particles back into the system," explains Prof Nielsen.
Concentrating the virus
The researchers extracted faeces from mice fed a standard low-fat diet over a period of time. The stool was then filtered so that all live bacteria were sorted out, while the virus particles — mainly bacteriophages — were concentrated. The viruses were transplanted via a tube into the mice that had been on high-fat diets for six weeks. The mice continued the fatty diet for another six weeks. Thereafter, the mice were examined after a glucose test and measured for weight gain.
The study addresses one of the current problems with faecal transplants. Today, stool is transplanted in an unfiltered form, in the belief that it is the gut bacteria which are most effective. However, in rare cases, the method produces side effects when diseases are inadvertently transmitted via the transplanted stool bacteria.
"Our study demonstrates that there is an effect after the live bacteria have been filtered from stool. Therefore, primarily virus particles are transmitted. This makes the method safer," says Prof Nielsen.
He expects that it will be a number of years before the method can be broadly deployed. More experiments are needed, and obviously, human trials as well.
"Mice are the first step. But because the findings suggest that it will work in humans, that is the next. Our hope is that, in the long term, a well-defined cocktail of bacteriophages can be developed that has a minimal risk of side effects," Prof Nielsen concludes.
Source: BMJ Gut
Nielsen. D. S., et al
"Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model"
